Kuros Biosciences AG (SWX:KURN)

Market Cap	910.43M +26.5%
Revenue (ttm)	115.82M +71.5%
Net Income	2.02M
EPS	0.05
Shares Out	39.18M
PE Ratio	450.08
Forward PE	87.04
Dividend	n/a
Ex-Dividend Date	n/a

Volume	47,288
Average Volume	240,896
Open	22.98
Previous Close	23.24
Day's Range	22.14 - 22.98
52-Week Range	14.00 - 34.20
Beta	0.63
RSI	44.33
Earnings Date	Mar 10, 2026

About Kuros Biosciences AG

Kuros Biosciences AG engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally. It operates through two segments, Medical Devices and Legacy Portfolio. The company provides MagnetOs Granules, an advanced bone graft based on the submicron needle-shaped NeedleGrip surface technology; MagnetOs Putty, a mold uses to fill bony voids for intervertebral disc space or posterolateral spine; and Attrax, a biphasic calcium phosphate bone graft...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2016
• Employees: 178
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: KURN

Financial Performance

Financial numbers in USD